Report

  • Home |
  • Reports |
  • Global Antibiotics Market by Product Type (Aminoglycosides, Beta-lactams (penici....
src

Global Antibiotics Market by Product Type (Aminoglycosides, Beta-lactams (penicillin, carbapenems, and cephalosporin), Macrolides, Phenicol, Quinolones/fluoroquinolones, Tetracycline, Sulfonamides and others) and by End-Users/Application (Hospitals, Homecare, Specialty Clinics & Others) Global Market Share, Forecast Data, In-Depth Analysis, and Detailed Overview, and Forecast, 2015 - 2027

The report on the global antibiotics market analyzes complete scenario i.e., existing as well as future visions of antibiotics market. It includes detailed overview of antibiotics market along with market pictures. Additionally, report has included complete data of the various segments in the global antibiotics market followed by its applications, end users and region wide segmentation. Moreover, report has highlights of global key players present in this market. Top global players are analyzed completely along with their financials, technological innovations, key developments, apart from future strategies, SWOT analysis, acquisitions & mergers, and market footprint.

Global antibiotics market report offers in-depth insights, revenue details, and other vital information regarding the global antibiotics market, and the various trends, drivers, restraints, opportunities, and threats in the target market till year 2027. Hence, it covers the impact of these drivers and restraints on demand for this market during the forecast period. The report also includes PEST analysis, Porter’s Five Forces analysis, and opportunity map analysis for in-depth understanding of the market.

It provides historical data along with future forecast as well as detailed analysis of market on a global, regional and country level. Important market data of this market is projected in the form of form of tables, graphics, and pictures. On a regional basis, the market is categorized into five regions that include North America, Europe, Asia Pacific, Latin America, and Middle & East Africa. It analyzes complete scenario of each and every region along with highest share holder of antibiotics market.

Market Segmentation:
Segmentation by Type Aminoglycosides 
Beta-lactams ( penicillin, carbapenems, and cephalosporin)
Macrolides
Phenicol
Quinolones/fluoroquinolones
Tetracycline
Sulfonamides
others
Segmentation by Application Hospitals
Homecare
Specialty Clinics 
Others
Market, By Regions North America (the United States, Canada, and Mexico)
Europe (Germany, UK, France, Italy, and Russia, etc.)
Asia-Pacific (China, Japan, ASEAN, India, and Korea)
The Middle East and Africa (UAE, Egypt, South Africa, Saudi Arabia)
South America (Brazil, Chile, Peru, and Argentina)

In addition, antibiotics market report sorted and categorized the information and data according to the major geographical regions which are expected to impact on the industry in forecast period.

Report also provides factors that are contributing to and influencing the expansion of the global antibiotics market. It projects the market assessment for the predicted time. Along with all these report includes the manufacturing process along with shipment, price, revenue, gross profit, potential, interview records, business distribution, etc. This enables users to get complete scenario of competitive analysis of the market.
 
Pivotal Fundamentals of the Global Antibiotics Market Report:
  • Holistic in-depth detailed analysis, regarding the parent market.
  • Detailed information about the current R&D activities performed by each antibiotics market player.
  • Region-wise and country-wise breakdown of the antibiotics market to get the revenue, and growth lookout in these areas.
  • Key factors which are influencing the consumption pattern of consumers across various regions and countries.
  • Historical and future progress of the global antibiotics market.
  • Year-on-year growth of the global antibiotics market in terms of value and volume.
Conclusion:
At last report covers a short outline of the dealers, distributors, and suppliers. Additionally, it provides sales channel, analysis findings and results. It spots some new entrants within the market. The study thus, suggests a brand new proposition to embellish antibiotics market and nurture business as it explains current global market as well as future market.
Chapter 1 Antibiotics Market Overview
1.1 Product Overview and Scope of Antibiotics

Chapter 2 Executive Summary 
2.1 Drivers for Antibiotics Market: 
2.2 Restrain for Antibiotics Market:
2.3 Opportunity for Antibiotics Market: 
2.4 Global Antibiotics market, 2015 - 2027
2.5 Global Antibiotics market, by Region, 2015 - 2027
2.6 Global Antibiotics market, by Type, 2015 - 2027
2.7 Global Antibiotics market, by Application, 2015 - 2027

Chapter 3 Antibiotics Segment by Types (Product Category) 
3.1 Global Antibiotics Revenue (USD Million) and Growth Rate (%) Comparison by Types (2015-2027) 
3.2 Global Antibiotics Revenue Market Share (%) by Types in 2019
3.3 Aminoglycosides 
3.4 Beta-lactams ( penicillin, carbapenems, and cephalosporin)
3.5 Macrolides
3.6 Phenicol
3.7 Quinolones/fluoroquinolones
3.8 Tetracycline
3.9 Sulfonamides
3.10 others

Chapter 4 Global Antibiotics Segment by Application 
4.1 Global Antibiotics Revenue (USD Million) Comparison by Application (2015-2027) 
4.2 Hospitals
4.3 Homecare
4.4 Specialty Clinics 
4.5 Others

Chapter 5 Global Antibiotics Market by Regions (2015-2027) 
5.1 Global Antibiotics Market Size and Growth Rate (%) Comparison by Regions (2015-2027) 
5.2 North America Antibiotics Status and Prospect (2015-2027) 
5.3 Europe Antibiotics Status and Prospect (2015-2027)
5.4 Asia Pacific Antibiotics Status and Prospect (2015-2027) 
5.5 South America Antibiotics Status and Prospect (2015-2027) 
5.6 Middle East & Africa Antibiotics Status and Prospect (2015-2027) 
5.7 Global Antibiotics Market Size (2015-2027) 
            5.7.1 Global Antibiotics Revenue Status and Outlook (2015-2027) 
            
Chapter 6 Global Antibiotics Market Competition by Manufacturers
6.1 Global Antibiotics Revenue and Share by Manufacturers (2015-2019) 

Chapter 7 Company (Top Players) Profiles and Key Data
7.1 Company 1. AstraZeneca plc
            7.1.1 Company 1 Basic Information and Sales Area
            7.1.2 Business Segment/ Overview
            7.1.3 Investment in Research and Development
            7.1.4 Antibiotics Product Types Specification
            7.1.5 Key Developments
            7.1.6 Business Strategy
            7.1.7 Key Financial Data (2015-2019)
7.2 Company 2. Bristol-Myers Squibb Co.
            7.2.1 Company 2 Basic Information and Sales Area
            7.2.2 Business Segment/ Overview
            7.2.3 Investment in Research and Development
            7.2.4 Antibiotics Product Types Specification
            7.2.5 Business Strategy
            7.2.6 Key Financial Data (2015-2019)
7.3 Company 3. Bayer HealthCare AG
            7.3.1 Company 3 Basic Information, and Sales Area
            7.3.2 Business Segment/ Overview
            7.3.3 Antibiotics Product Types Specification
            7.3.4 Key Developments
            7.3.5 Business Strategy
            7.3.6 Key Financial Data (2015-2019)
7.4 Company 4. GlaxoSmithKline plc
            7.4.1 Company 4 Basic Information and Sales Area. 
            7.4.2 Business Segment/ Overview
            7.4.3 Antibiotics Product Types Specification
            7.4.4 Business Strategy
            7.4.5 Key Financial Data (2015-2019)
7.5 Company 5. Eli Lilly and Company
            7.5.1 Company 5 Basic Information and Sales Area. 
            7.5.2 Business Segment/ Overview
            7.5.3 Antibiotics Product Types Specification
            7.5.4 Business Strategy
            7.6.5 Key Financial Data (2015-2019)
7.6 Company 6. Johnson & Johnson
            7.6.1 Company 6 Basic Information, and Sales Area
            7.6.2 Business Segment/ Overview
            7.6.3 Antibiotics Product Types Specification
            7.6.4 Business Strategy
            7.6.5 Key Financial Data (2015-2019)
7.7 Company 7. Merck & Co.
            7.7.1 Company 7 Basic Information, and Sales Area
            7.7.2 Business Segment/ Overview
            7.7.3 Investment in Research and Development
            7.7.4 Antibiotics Product Types Specification
            7.7.5 Key Developments
            7.7.6 Business Strategy
            7.7.7 Key Financial Data (2015-2019)
7.8 Company 8. Novartis AG
            7.8.1 Company 8 Basic Information and Sales Area. 
            7.8.2 Business Segment/ Overview
            7.8.3 Antibiotics Product Types Specification
            7.8.4 Business Strategy
            7.8.5 Key Financial Data (2015-2019)
7.9 Company 9. Sanofi
            7.9.1 Company 9 Basic Information, and Sales Area
            7.9.2 Business Segment/ Overview
            7.9.3 Antibiotics Product Types Specification
            7.9.4 Business Strategy
            7.9.5 Key Financial Data (2015-2019)
7.10 Company 10. Teva Pharmaceutical Industries Ltd.
            7.10.1 Company 10 Basic Information, and Sales Area
            7.10.2 Business Segment/ Overview
            7.10.3 Antibiotics Product Types Specification
            7.10.4 Business Strategy
            7.10.5 Key Financial Data (2015-2019)
            
Chapter 8 Global Antibiotics Revenue by Regions (2015-2027) 
8.1 Global Antibiotics Revenue and Market Share (%) by Regions (2015-2027) 

Chapter 9 Global Antibiotics Revenue by Types
9.1 Global Antibiotics Revenue and Market Share (%) by Types (2015-2027) 

Chapter 10 Global Antibiotics Market Analysis by Application
10.1 Global Antibiotics Revenue (USD Million) and Market Share (%) by Application (2015-2027) 
10.2 Global Antibiotics Revenue Growth Rate by Application (2015-2027)
 
Chapter 11 North America Antibiotics Market Development Status and Outlook
11.1 North America Antibiotics Market Size (2015-2027) 
            11.1.1 North America Antibiotics Market Size by Type (USD Million) (2015-2027) 
11.2 North America Antibiotics Market Size (2015-2027) 
            11.2.1 North America Antibiotics Market Size by Application (USD Million) (2015-2027) 
11.3 U.S
            11.3.1 U.S. Antibiotics market, by Type, 2015 - 2027
            11.3.2 U.S. Antibiotics market, by Application, 2015 – 2027
11.4 Canada
            11.4.1 Canada Antibiotics market, by Type, 2015 - 2027
            11.4.2 Canada Antibiotics market, by Application, 2015 – 2027
11.5 Mexico
            11.5.1 Mexico Antibiotics market, by Type, 2015 - 2027
            11.5.2 Mexico Antibiotics market, by Application, 2015 – 2027
            
Chapter 12 Europe Antibiotics Market Development Status and Outlook
12.1 Europe Antibiotics Market Size (2015-2027) 
            12.1.1 Europe Antibiotics Market Size by Type (USD Million) (2015-2027) 
12.2 Europe Antibiotics Market Size (2015-2027) 
            12.2.1 Europe Antibiotics Market Size by Application (USD Million) (2015-2027) 
12.3 U.K.
            12.3.1 U.K. Antibiotics market, by Type, 2015 - 2027
            12.3.2 U.K. Antibiotics market, by Application, 2015 – 2027
12.4 Germany
            12.4.1 Germany Antibiotics market, by Type, 2015 - 2027
            12.4.2 Germany Antibiotics market, by Application, 2015 – 2027
12.5 France
            12.5.1 France Antibiotics market, by Type, 2015 – 2027
            12.5.2 France Antibiotics market, by Application, 2015 – 2027
12.6 Italy
            12.6.1 Italy Antibiotics market, by Type, 2015 – 2027
            12.6.2 Italy Antibiotics market, by Application, 2015 – 2027
12.7 Spain
            12.7.1 Spain Antibiotics market, by Type, 2015 – 2027
            12.7.2 Spain Antibiotics market, by Application, 2015 – 2027
12.8 Rest of Europe
            12.8.1 Rest of Europe Antibiotics market, by Type, 2015 – 2027
            12.8.2 Rest of Europe Antibiotics market, by Application, 2015 – 2027
            
Chapter 13 Asia Pacific Antibiotics Market Development Status and Outlook
13.1 Asia Pacific Antibiotics Market Size (2015-2027) 
            13.1.1 Asia Pacific Antibiotics Market Size by Type (USD Million) (2015-2027) 
13.2 Asia Pacific Antibiotics Market Size (2015-2027) 
            13.2.1 Asia Pacific Antibiotics Market Size by Application (USD Million) (2015-2027) 
13.3 China
            13.3.1 China Antibiotics market, by Type, 2015 – 2027
            13.3.2 China Antibiotics market, by Application, 2015 – 2027
13.4 Japan
            13.4.1 Japan Antibiotics market, by Type, 2015 – 2027
            13.4.2 Japan Antibiotics market, by Application, 2015 – 2027
13.5 India
            13.5.1 India Antibiotics market, by Type, 2015 – 2027
            13.5.2 India Antibiotics market, by Application, 2015 – 2027
13.6 Southeast Asia
            13.6.1 Southeast Asia Antibiotics market, by Type, 2015 – 2027
            13.6.2 Southeast Asia Antibiotics market, by Application, 2015 – 2027
            
Chapter 14 South America Antibiotics Market Development Status and Outlook
14.1 South America Antibiotics Market Size (2015-2027) 
            14.1.1 South America Antibiotics Market Size by Type (USD Million) (2015-2027) 
14.2 South America Antibiotics Market Size (2015-2027) 
            14.2.1 South America Antibiotics Market Size by Application (USD Million) (2015-2027) 
14.3 Brazil
            14.3.1 Brazil Antibiotics market, by Type, 2015 – 2027
            14.3.2 Brazil Antibiotics market, by Application, 2015 – 2027 
14.4 Argentina
            14.4.1 Argentina Antibiotics market, by Type, 2015 – 2027
            14.4.2 Argentina Antibiotics market, by Application, 2015 – 2027 
14.5 Colombia
            14.5.1 Colombia Antibiotics market, by Type, 2015 – 2027
            14.5.2 Colombia Antibiotics market, by Application, 2015 – 2027
14.6 Rest of South America
            14.6.1 Colombia Antibiotics market, by Type, 2015 – 2027
            14.6.2 Colombia Antibiotics market, by Application, 2015 – 2027
            
Chapter 15 Middle East & Africa Antibiotics Market Development Status and Outlook
15.1 Middle East & Africa Antibiotics Market Size (2015-2027) 
            15.1.1 Middle East & Africa Antibiotics Market Size by Type (USD Million) (2015-2027) 
15.2 Middle East & Africa Antibiotics Market Size (2015-2027) 
            15.2.1 Middle East & Africa Antibiotics Market Size by Application (2015-2027) 
15.3 UAE
            15.3.1 UAE Antibiotics market, by Type, 2015 – 2027
            15.3.2 UAE Antibiotics market, by Application, 2015 – 2027
15.4 South Africa
            15.4.1 South Africa Antibiotics market, by Type, 2015 – 2027
            15.4.2 South Africa Antibiotics market, by Application, 2015 – 2027
15.5 Egypt
            15.5.1 Egypt Antibiotics market, by Type, 2015 – 2027
            15.5.2 Egypt Antibiotics market, by Application, 2015 – 2027
15.6 Rest of MEA
            15.6.1 Rest of MEA Antibiotics market, by Type, 2015 – 2027
            15.6.2 Rest of MEA Antibiotics market, by Application, 2015 – 2027
            
Chapter 16 Antibiotics Manufacturing Cost Analysis
16.1 Proportion of Manufacturing Cost Structure
            16.1.1 Raw Materials
            16.1.2 Labor Cost
            16.1.3 USA Labor Cost Analysis
            16.1.4 EU Labor Costs Analysis
            16.1.5 China Labor Costs Analysis
            16.1.6 Manufacturing Expenses
            
Chapter 17 Marketing Strategy Analysis, Distributors/ Traders
17.1 Marketing Channel
            17.1.1 Direct Marketing
            17.1.2 Indirect Marketing
            17.1.3 Marketing Channel Development Trend
17.2 Market Positioning
            17.2.1 Pricing Strategy
            
Chapter 18 Research Findings and Conclusion
 
No Methodology
Global Antibiotics Market Trends:
The global antibiotics is estimated to be worth USD 46.37 billion in 2019 and is projected to reach USD 53.07 billion by 2027, at a CAGR of 1.5% from 2020 to 2027.

Antibiotic also called an antibacterial, is a type of antimicrobial drug used in the treatment and prevention of bacterial infections. Antibiotics are also known as antibacterial or antimicrobials. They may either kill or inhibit the growth of bacteria. A limited number of antibiotics also possess antiprotozoal activity. Antibiotics are not effective against viruses such as the common cold or influenza; drugs which inhibit viruses are termed antiviral drugs or antivirals rather than antibiotics. Since the discovery of the antibiotic penicillin in 1920, various antibiotic compounds have been used to treat several bacterial infections.

The growth of the antibiotics is driven by the development of novel approaches for new antibiotics for treating bacterial infections and a large number of clinical trials. Additionally, increase in incidence of infectious diseases such as HIV/AIDS, pneumonia, malaria, and tuberculosis, and the current gap in the demand and supply of antibiotics are the other factors propelling the market. While, the discovery of advanced prospect molecules and introduction of novel combination therapies to treat antibiotic-resistant microbial infections are expected to provide new opportunities for market players in the near future. However, the  lack of research & development activity for the development of newer molecules are hampering the growth of the antibiotics market.

Global Antibiotics Market, By Type:
Based on the type, the global market is categorized into Aminoglycosides, Beta-lactams (penicillin, carbapenems, and cephalosporin), Macrolides, Phenicol, Quinolones/fluoroquinolones, Tetracycline, Sulfonamides  and others. On the basis of type, Quinolones/fluoroquinolones accounted for largest share of total revenue generated due to the surge in demand for broad-spectrum property. While its bactericidal activity is the key factor for the growth of the segment. Moreover, the new generation quinolones enhanced oral bioavailability along with superior tissue penetration; and improved safety & tolerability. These advantages are increasing the demand for this segment which is boosting the antibiotics market.
 
Global Antibiotics, By Application:
Based on the application, the global market is categorized into Hospitals, Homecare, Specialty Clinics & Others. The demand of Global Antibiotics Market is highest from Hospitals, due to  the presence of hospitals worldwide and increasing health issues led to increase in the demand for antibiotics. While favorable regulations, improvement in infrastructure, increasing economic conditions, awareness amongst people led to fueling the growth of the hospitals which is boosting the antibiotics market.

Global Antibiotics market, By Region:
Report covers the region wise analysis, global antibiotics market can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Among all, Asia Pacific leads the global antibiotics market share followed by North-America  and Europe. While the  Asia Pacific leads the global antibiotics market due to the prevalence of various infectious diseases, favorable regulatory reforms, increase in population & unhygienic conditions giving rise to antibiotic resistance bacteria, and significant demand for generic medicines. All these factors led to the growth of the antibiotics market in Asia-Pacific region.

Major Market Players:
The research study includes profiles of leading companies operating in the global antibiotics market. Key players profiled in the report include: AstraZeneca plc, Bristol-Myers Squibb Co., Bayer HealthCare AG, GlaxoSmithKline plc, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Novartis AG ,Sanofi, and Teva Pharmaceutical Industries Ltd.
GlaxoSmithKline plc announced that patient dosing has begun in a phase III clinical program investigating Gepotidacin, the first in a new chemical class of antibiotics called Triazaacenaphthylene bacterial topoisomerase inhibitors, in patients with uncomplicated urinary tract infection (UTI, also known as acute cystitis) and urogenital gonorrhea (GC).

Global Antibiotics Market Report Scope:
Report Parameters Details of Parameter
Market Size 2015-2027
Based Year 2019
Forecast Period Covered 2020-2027
Units for value USD (Million)
Covered Segments Product Type, Applications, Geographic Regions
Product Type Aminoglycosides, Beta-lactams ( penicillin, carbapenems, and cephalosporin), Macrolides, Phenicol, Tetracycline, Quinolones/fluoroquinolones, Sulfonamides  and others
Applications Hospitals, Homecare, Specialty Clinics & Others
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Covered AstraZeneca plc, Bristol-Myers Squibb Co., Bayer HealthCare AG, GlaxoSmithKline plc, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Novartis AG ,Sanofi, and Teva Pharmaceutical Industries Ltd

The report analyzes all the factors which are impacting on the market and on that basis describes the drivers, restraints, and opportunities for the growth of the global antibiotics market. Similarly, report provides the all the segmentations along with the qualitative analysis.

Global Antibiotics Market: Product analysis
  • Aminoglycosides
  • Beta-lactams ( penicillin, carbapenems, and cephalosporin)
  • Macrolides
  • Phenicol
  • Quinolones/fluoroquinolones
  • Tetracycline
  • Sulfonamides
  • others
Global Antibiotics Market: Application analysis
  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others
Market, By regions:
In addition, antibiotics report sorted and categorized the information and data according to the major geographical regions which are expected to impact on the industry in forecast period. Following are the regions we covered in this report:
  • North America (U.S., Canada, Mexico)
  • Europe (U.K., France, Germany, Spain, Italy, Central & Eastern Europe, CIS)
  • Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific)
  • Latin America (Brazil, Rest of L.A.)
  • Middle East and Africa (Turkey, GCC, Rest of Middle East)